Skip to main content

Boothbay Fund Management, LLC

SEC CIK
0001549230
Latest filing
Aug 14, 2026

The latest 13F from Boothbay Fund Management, LLC covers Q2 2026 (filed Aug 14, 2026): 1,962 long positions worth $5.21B. The top 10 holdings make up 9.9% of the portfolio, and the largest is Revolution Medicines, Inc. (RVMD) at 1.7%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
638
Est. +$993.5M
Added
575
Est. +$1.13B
Reduced
542
Est. −$1.26B
Sold out
454
Est. −$628.6M

Top 5 holdings

Share of this quarter's portfolio value

  1. RVMDRevolution Medicines, Inc.
    1.7%$87.2MHistory
  2. ABVXAbivax S.A.
    1.4%$75.1MHistory
  3. CLMCornerstone Strategic Investment Fund, Inc.
    1.0%$50.9MHistory
  4. LQDALiquidia Corp
    1.0%$49.6MHistory
  5. AMTAmerican Tower Corp
    0.9%$46.7MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. AMTAmerican Tower Corp
    +$46.5MAddedHistory
  2. BPBP PLC
    +$36.4MNewHistory
  3. MMM3M Co
    +$29.5MAddedHistory
  4. DLRDigital Realty Trust, Inc.
    +$29.4MNewHistory
  5. BZHBeazer Homes USA Inc
    +$25.2MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. AMTAmerican Tower Corp
    +0.89 pp<0.1% → 0.9%History
  2. BPBP PLC
    +0.70 pp0.0% → 0.7%History
  3. RVMDRevolution Medicines, Inc.
    +0.67 pp1.0% → 1.7%History
  4. DLRDigital Realty Trust, Inc.
    +0.56 pp0.0% → 0.6%History
  5. MMM3M Co
    +0.56 pp0.1% → 0.6%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. STXSeagate Technology Holdings plc
    −$49.3MReducedHistory
  2. MUMicron Technology Inc
    −$43.6MReducedHistory
  3. GEGeneral Electric Co
    −$33.2MReducedHistory
  4. ASMLASML Holding NV
    −$28.9MReducedHistory
  5. TERNTerns Pharmaceuticals, Inc.
    −$25.6MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. TERNTerns Pharmaceuticals, Inc.
    −0.60 pp0.6% → 0.0%History
  2. GEGeneral Electric Co
    −0.58 pp0.7% → 0.1%History
  3. MLYSMineralys Therapeutics, Inc.
    −0.56 pp0.6% → 0.1%History
  4. TAT&T Inc.
    −0.51 pp0.5% → <0.1%History
  5. SOCSable Offshore Corp.
    −0.48 pp0.6% → 0.1%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$5.21B
+$956.5M (+22.5%) vs. prior quarter
Positions
1,962
+184 vs. prior quarter
Top 10 concentration
9.9%
Top 10 as share of value
Turnover
40.0%
Q2 2026, one quarter
Average holding period
6.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $5.21B (Q2 2026)

Q1 2021: $1.87BQ2 2021: $2.43BQ3 2021: $2.50BQ4 2021: $3.03BQ1 2022: $3.07BQ2 2022: $2.89BQ3 2022: $2.94BQ4 2022: $2.97BQ1 2023: $3.50BQ2 2023: $2.91BQ3 2023: $2.84BQ4 2023: $2.68BQ1 2024: $3.38BQ2 2024: $3.08BQ3 2024: $3.17BQ4 2024: $3.22BQ1 2025: $2.79BQ2 2025: $3.19BQ3 2025: $3.87BQ4 2025: $3.81BQ1 2026: $4.26BQ2 2026: $5.21B
Q1 2021Q2 2026
13F filings of Boothbay Fund Management, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 20261,962$5.21BRVMDABVXCLMvs. Q1 2026SEC
Q1 2026May 15, 20261,778$4.26BABVXCLMAMZNvs. Q4 2025SEC
Q4 2025Feb 17, 20261,705$3.81BABVXNVDAEQIXvs. Q3 2025SEC
Q3 2025Nov 14, 20251,585$3.87BNVDACLMABVXvs. Q2 2025SEC
Q2 2025Aug 14, 20251,216$3.19BCLMNVDAVRNAvs. Q1 2025SEC
Q1 2025May 15, 20251,184$2.79BNVDACLMSPYvs. Q4 2024SEC
Q4 2024Feb 14, 20251,275$3.22BBITBFBTCIBITvs. Q3 2024SEC
Q3 2024Nov 14, 20241,373$3.17BCLMDELLSBACvs. Q2 2024SEC
Q2 2024Aug 14, 20241,307$3.08BIBITBITBGBTCvs. Q1 2024SEC
Q1 2024May 15, 20241,351$3.38BIBITFBTCSPYvs. Q4 2023SEC
Q4 2023Feb 14, 20241,440$2.68BCLMCEFXvs. Q3 2023SEC
Q3 2023Nov 14, 20231,479$2.84BVMWATVICLMvs. Q2 2023SEC
Q2 2023Aug 14, 20231,508$2.91BSPYCLMMSFTvs. Q1 2023SEC
Q1 2023May 15, 20231,834$3.50BPalo Alto Networks IncCLMUnited States STL Corp Newvs. Q4 2022SEC
Q4 2022Feb 14, 20231,700$2.97BSPYCLMUnited States STL Corp Newvs. Q3 2022SEC
Q3 2022Nov 14, 20221,905$2.94BSPYCLMOccidental Pete Corp WT Exp 080327vs. Q2 2022SEC
Q2 2022Aug 15, 20221,934$2.89BSPYLiberty Media Corp DelOccidental Pete Corp WT Exp 080327vs. Q1 2022SEC
Q1 2022May 16, 20221,854$3.07BiShares TrLiberty Media Corp DelUnited States STL Corp Newvs. Q4 2021SEC
Q4 2021Feb 14, 20221,641$3.03BAMZNPFECRMvs. Q3 2021SEC
Q3 2021Nov 15, 20211,610$2.50BCIVITrump Media & Technology Group Corp.WLLvs. Q2 2021SEC
Q2 2021Aug 17, 2021Amended1,638$2.43BEGLXFWTWGOOGLvs. Q1 2021SEC
Q1 2021May 17, 20211,264$1.87BDENMastercard IncorporatedGOOGL–SEC

13D and 13G filings

Companies where Boothbay Fund Management, LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Boothbay Fund Management, LLC does not currently report owning 5% or more of any company.

Latest filings

171 filings on file made by Boothbay Fund Management, LLC or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Boothbay Fund Management, LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
SQNSSequans CommunicationsNov 14, 202510:55 AM ET13G/A0.00%0 shares–Below 5%Sep 30, 2025SEC
ASPCUASPAC III Acquisition Corp.Nov 14, 202510:48 AM ET13G/A0.00%0 shares–Below 5%Sep 30, 2025SEC
BZAIBlaize Holdings, Inc.Nov 14, 202510:42 AM ET13G/A0.00%0 shares−8.40 ppfrom 8.40%Below 5%Sep 30, 2025SEC
Horizon Space Acquisition II Corp.Ordinary shares, par value $0.0001 per shareNov 14, 202510:36 AM ET13G/A0.00%0 shares–Below 5%Sep 30, 2025SEC
RTACRenatus Tactical Acquisition Corp IAug 7, 20252:47 PM ET13G/A3.10%738.4K shares−6.50 ppfrom 9.60%Below 5%Jun 30, 2025SEC
FBRXForte Biosciences, Inc.Aug 7, 20252:43 PM ET13G/A0.80%53.8K shares−5.20 ppfrom 6.00%Below 5%Jun 30, 2025SEC
RTACRenatus Tactical Acquisition Corp IMay 21, 20255:19 PM ET13G9.60%1.67M sharesNewMay 15, 2025SEC
QETAQuetta Acquisition CorpApr 29, 20259:48 AM ET13G/A0.00%100 shares–Below 5%Mar 31, 2025SEC
CHARCharlton Aria Acquisition CorpApr 14, 20259:16 AM ET13G/A3.40%304.9K shares–Below 5%Mar 31, 2025SEC
Graphex Group LtdAmerican Depositary Shares, each representing 20 ordinary shares at par value of HK $0.01Feb 13, 202511:45 AM ET13G/A3.60%2.09M shares–Below 5%Dec 31, 2024SEC
BYNObyNordic Acquisition CorpFeb 13, 202511:39 AM ET13G/A2.90%112.8K shares–Below 5%Dec 31, 2024SEC
Alphatime Acquisition CorpOrdinary Shares, par value $0.0001Feb 13, 202511:37 AM ET13G/A2.80%188.1K shares–Below 5%Dec 31, 2024SEC
YHNAUYHN Acquisition I LtdFeb 13, 202511:31 AM ET13G/A1.30%104.7K shares–Below 5%Dec 31, 2024SEC
FBRXForte Biosciences, Inc.Feb 13, 202511:20 AM ET13G6.00%88.8K sharesNewDec 31, 2024SEC
BZAIBlaize Holdings, Inc.Jan 21, 20251:49 PM ET13G8.40%343.6K sharesNewJan 14, 2025SEC
Horizon Space Acquisition II Corp.Nov 22, 202413GOld format–New–SEC
BYNObyNordic Acquisition CorpNov 20, 202413GOld format–New–SEC
Alphatime Acquisition CorpNov 18, 202413G/AOld format–––SEC
ASPCASPAC III Acquisition Corp.Nov 14, 202413GOld format–New–SEC
ALIMAlimera Sciences IncNov 7, 202413G/AOld format–––SEC